IP Library Granted Patent US 11,525,166
Granted Patent B2
US 11,525,166 · App. 17/699,950 · Granted Dec 13, 2022

Rapid diagnostic test for LAMP

Inventors: Nathan Tanner (West Newbury, MA); Yinhua Zhang (North Reading, MA); Eric Hunt (Danvers, MA); Gregory Patton (Peabody, MA); Guoping Ren (Danvers, MA); Zhiru Li (Lexington, MA); Andrew Barry (Ipswich, MA); Nicole Nichols (Reading, MA); Catherine B. Poole (Medford, MA); Harriet M. Strimpel (Manchester, MA); Ivan R. Correa, Jr. (Hamilton, MA); Clotilde Carlow (Ipswich, MA); Esta Slayton (Epping, NH)
Assignee: New England Biolabs, Inc.
C12Q1/701G01N21/78
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,525,166
App. No.
17/699,950
Granted
Dec 13, 2022
Kind
B2
Abstract

Kits and methods are described that are directed to specific and sensitive methods of target nucleic acid detection and more specifically detecting target nucleic acids directly from biological samples. The kits and methods were developed to be easy to use involving a minimum number of steps and giving rapid and consistent results either at point of care or in high throughput situations. The kits and methods utilize in various combinations, reversible inhibitors of kit components, thermolabile enzymes, poloxamers, various salts, indicators and one or more Loop-Mediated Isothermal Amplification (LAMP) primer sets for detecting single and/or multiple targets and variants of the targets including SARS-CoV-2 targets and variants thereof in a single reaction. The kits and methods permit detection of the target nucleic with similar sensitivity regardless of the presence of undefined mutations that may enhance the virulence of cells or viruses containing the undefined mutations.

Claims (17)

1. A facemask for detecting a pathogen, the face mask comprising:

(a) A lysis reagent for disrupting the pathogen received by the mask in an aqueous aerosol, to release nucleic acid;

(b) a lyophilized isothermal amplification mixture; the lyophilized amplification mixture comprising a polymerase, and one or more primers for hybridizing to the nucleic acid; and

(c) a signaling reagent for reporting a positive amplification reaction.

2. The facemask according to claim 1 , wherein the aqueous aerosol is saliva or nasal effluent from a person other than the mask wearer.

3. The facemask according to claim 1 , wherein the lysis mixture is compartmentally separated from the amplification mixture.

4. The facemask according to claim 1 , wherein the facemask further comprises a reagent in the amplification mixture capable of generating an exothermic chemical reaction when contacted by the lysis mixture after contact with the aqueous aerosol, wherein the exothermic reaction initiates the amplification reaction.

5. The facemask according to claim 1 , wherein the signaling reagent produces a color change caused by release of pyrophosphate.

6. The facemask according to claim 1 , wherein the signaling reagent is a sound.

7. The facemask according to claim 1 , wherein the lyophilized amplification mixture is immobilized on a substrate.

8. The facemask according to claim 7 , wherein the immobilized substrate is beads.

9. A method for detecting a pathogen in an environment, comprising:

(a) obtaining a fabric containing a lysis reagent, lyophilized isothermal amplification mixture; and a signaling reagent;

(b) receiving an aerosol from a third party or from the wearer of the fabric;

(c) lysing the pathogen to release nucleic acids by reagents in the fabric;

(d) amplifying the nucleic acids by amplification reagents in the fabric; and

(e) producing a visible or audible signal if the nucleic acids from the pathogen are present in the received aerosol.

Assignments (2)
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Sep 27, 2023
From: NEW ENGLAND BIOLABS, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 065044/0729 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2022
From: TANNER, NATHAN; ZHANG, YINHUA; HUNT, ERIC; PATTON, GREGORY; REN, GUOPING; BARRY, ANDREW; LI, ZHIRU; NICHOLS, NICOLE; POOLE, CATHERINE B.; STRIMPEL, HARRIET M.; CORREA, IVAN R., JR.; CARLOW, CLOTILDE; SLAYTON, ESTA
To: NEW ENGLAND BIOLABS, INC.
Reel/Frame 059480/0377 →
Continuity (16)
Continuation 17406959 · Aug 19, 2021
Continuation In Part 17221451 · Apr 2, 2021
Continuation 17178395 · Feb 18, 2021
Continuation 17122979 · Dec 15, 2020
Continuation 16938575 · Jul 24, 2020
Provisional Application 63165465 · Mar 24, 2021
Provisional Application 63165465 · Mar 24, 2021
Provisional Application 63106120 · Oct 27, 2020
Provisional Application 63068564 · Aug 21, 2020
Provisional Application 63048556 · Jul 6, 2020
Provisional Application 63027216 · May 19, 2020
Provisional Application 63022303 · May 8, 2020
Provisional Application 63013442 · Apr 21, 2020
Provisional Application 63001909 · Mar 30, 2020
Provisional Application 62988696 · Mar 12, 2020
Related Publication 20220213564A1 · Jul 7, 2022